Alerts will be sent to your verified email
Verify EmailHESTERBIO
Balance sheet of Hester Biosciences is strong.
It shouldn't have solvency or liquidity issues.
Yes, The debt of Hester Biosciences is increasing.
Latest debt of Hester Biosciences is ₹222 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹210 Crs.
The profit is oscillating.
The profit of Hester Biosciences is ₹30.41 Crs for TTM, ₹18.89 Crs for Mar 2024 and ₹26.63 Crs for Mar 2023.
The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Hester Biosciences latest dividend payout ratio is 27.02% and 3yr average dividend payout ratio is 24.74%
Companies resources are majorly tied in miscellaneous assets